Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus monotherapy versus prednisone in adults with minimal change nephrotic syndrome
ChiCTR-TRC-11001454Phase 4Completed
- Sponsor
- San Antonio Kidney Disease Center
- Start
- Aug 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus and prednisone in nephrosis (2 arms), sponsored by San Antonio Kidney Disease Center. Primary endpoints: Clinical remission rate at 12 weeks and Clinical remission rate at end of study. Started Aug 2011; status: completed.
02
Drugs
tacrolimusprednisone
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001454.